Repetitive transcranial magnetic stimulation for the treatment of major depression in a patient with an intracranial space-occupying lesion

A case report of safety

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This is the first case report of the safety of therapeutic repetitive transcranial magnetic stimulation (rTMS) in a patient with an intracranial space-occupying lesion who had recurrent major depression. In this case, the intracranial space-occupying lesion was a mixed cystic and solid enhancing pineal region mass measuring approximately 16.9 × 12.2 × 15.5 mm. The patient remitted from depression with 36 sessions of dorsolateral prefrontal cortex rTMS treatments over a 6-week period. During the rTMS treatment course, patient's medication list included bupropion that potentially can increase the risk for a seizure and topiramate that potentially can reduce the risk for seizure associated with the treatment. The patient tolerated the rTMS treatment well, reporting only transient headache and discomfort at the site of stimulation after the treatment. She tolerated the procedure well and had no incidental seizure activity throughout her treatment sessions.

Original languageEnglish (US)
Pages (from-to)62-64
Number of pages3
JournalJournal of ECT
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Transcranial Magnetic Stimulation
Safety
Seizures
Therapeutics
Bupropion
Prefrontal Cortex
Headache

Keywords

  • brain tumor
  • intracranial space-occupying lesion
  • rTMS
  • seizure
  • transcranial magnetic stimulation

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Cite this

@article{589022adab2b4231bf1b352574091543,
title = "Repetitive transcranial magnetic stimulation for the treatment of major depression in a patient with an intracranial space-occupying lesion: A case report of safety",
abstract = "This is the first case report of the safety of therapeutic repetitive transcranial magnetic stimulation (rTMS) in a patient with an intracranial space-occupying lesion who had recurrent major depression. In this case, the intracranial space-occupying lesion was a mixed cystic and solid enhancing pineal region mass measuring approximately 16.9 × 12.2 × 15.5 mm. The patient remitted from depression with 36 sessions of dorsolateral prefrontal cortex rTMS treatments over a 6-week period. During the rTMS treatment course, patient's medication list included bupropion that potentially can increase the risk for a seizure and topiramate that potentially can reduce the risk for seizure associated with the treatment. The patient tolerated the rTMS treatment well, reporting only transient headache and discomfort at the site of stimulation after the treatment. She tolerated the procedure well and had no incidental seizure activity throughout her treatment sessions.",
keywords = "brain tumor, intracranial space-occupying lesion, rTMS, seizure, transcranial magnetic stimulation",
author = "Sandarsh Surya and Rosenquist, {Peter B.} and McCall, {William Vaughn}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/YCT.0000000000000245",
language = "English (US)",
volume = "32",
pages = "62--64",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Repetitive transcranial magnetic stimulation for the treatment of major depression in a patient with an intracranial space-occupying lesion

T2 - A case report of safety

AU - Surya, Sandarsh

AU - Rosenquist, Peter B.

AU - McCall, William Vaughn

PY - 2016/1/1

Y1 - 2016/1/1

N2 - This is the first case report of the safety of therapeutic repetitive transcranial magnetic stimulation (rTMS) in a patient with an intracranial space-occupying lesion who had recurrent major depression. In this case, the intracranial space-occupying lesion was a mixed cystic and solid enhancing pineal region mass measuring approximately 16.9 × 12.2 × 15.5 mm. The patient remitted from depression with 36 sessions of dorsolateral prefrontal cortex rTMS treatments over a 6-week period. During the rTMS treatment course, patient's medication list included bupropion that potentially can increase the risk for a seizure and topiramate that potentially can reduce the risk for seizure associated with the treatment. The patient tolerated the rTMS treatment well, reporting only transient headache and discomfort at the site of stimulation after the treatment. She tolerated the procedure well and had no incidental seizure activity throughout her treatment sessions.

AB - This is the first case report of the safety of therapeutic repetitive transcranial magnetic stimulation (rTMS) in a patient with an intracranial space-occupying lesion who had recurrent major depression. In this case, the intracranial space-occupying lesion was a mixed cystic and solid enhancing pineal region mass measuring approximately 16.9 × 12.2 × 15.5 mm. The patient remitted from depression with 36 sessions of dorsolateral prefrontal cortex rTMS treatments over a 6-week period. During the rTMS treatment course, patient's medication list included bupropion that potentially can increase the risk for a seizure and topiramate that potentially can reduce the risk for seizure associated with the treatment. The patient tolerated the rTMS treatment well, reporting only transient headache and discomfort at the site of stimulation after the treatment. She tolerated the procedure well and had no incidental seizure activity throughout her treatment sessions.

KW - brain tumor

KW - intracranial space-occupying lesion

KW - rTMS

KW - seizure

KW - transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=84959871453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959871453&partnerID=8YFLogxK

U2 - 10.1097/YCT.0000000000000245

DO - 10.1097/YCT.0000000000000245

M3 - Article

VL - 32

SP - 62

EP - 64

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 1

ER -